Huang, Wenxi
Tang, Huilin
Li, Yujia
Chen, Wei-Han
Chang, Shao-Hsuan
Bian, Jiang
Ahmed, Mustafa M
Kimmel, Stephen E
Guo, Jingchuan https://orcid.org/0000-0001-9799-2592
Funding for this research was provided by:
Pharmaceutical Research and Manufacturers of America Foundation
University of Florida
Article History
Accepted: 18 June 2025
First Online: 11 July 2025
Declarations
:
: PhRMA Foundation Research Starter Award (PI: Guo) and University of Florida Research Opportunity Seed Fund (PI: Guo).
: Guo received a consulting fee from Pfizer, outside the current work. Wenxi Huang, Huilin Tang, Yujia Li, Wei-Han Chen, Shao-Hsuan Chang, Jiang Bian, Mustafa M Ahmed, and Stephen Kimmel declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript.
: Conceptualization: JG. Methodology: WH, HT, and JG. Formal analysis: WH, HT, YL, WC, and SC. Resources: JG. Writing—initial draft: WH. Writing—review and editing: WH, HT, YL, WC, SC, JB, MA, SK, and JG. Supervision: JG. All authors have read and agreed to the published version of the manuscript.
: The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.